메뉴 건너뛰기
Scottish Medical Journal
Volumn 57, Issue 1, 2012, Pages 48-49
The importance of informed consent in patients with wet age-related macular degeneration considering intravitreal anti-vascular endothelial growth factor treatments
Author keywords

Anti VEGF; Informed consent; Macular degeneration; Pigment epithelial detachments; RPE rips
Indexed keywords

PEGAPTANIB; RANIBIZUMAB; VASCULOTROPIN INHIBITOR;
EID: 84858067041     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/smj.2011.011290     Document Type: Article
Times cited : (2)
References (8)
  • 1
    • 39349095670 scopus 로고    scopus 로고
    • Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularisation
    • Arias L, Caminal JM, Rubio M, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularisation. Eur J Ophthalmol 2007;17:992-5
    • (2007) Eur J Ophthalmol , vol.17 , pp. 992-995
    • Arias, L.1    Caminal, J.M.2    Rubio, M.3
  • 2
    • 34250210397 scopus 로고    scopus 로고
    • RPE tears after pegaptanib treatment in age-related macular degeneration
    • Chang L, Flaxel CJ, Lauer AK, et al. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 2007;27:857-63
    • (2007) Retina , vol.27 , pp. 857-863
    • Chang, L.1    Flaxel, C.J.2    Lauer, A.K.3
  • 3
    • 40249108608 scopus 로고    scopus 로고
    • Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD: Frequency and progress
    • Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD: frequency and progress. Ophthalmologe 2008;105:158-64
    • (2008) Ophthalmologe , vol.105 , pp. 158-164
    • Kook, D.1    Wolf, A.2    Neubauer, A.S.3
  • 4
    • 34250176573 scopus 로고    scopus 로고
    • Retinal pigment epithelial tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration
    • Ronan S, Yoganathan P, Chien FY, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina 2007;27:535-40
    • (2007) Retina , vol.27 , pp. 535-540
    • Ronan, S.1    Yoganathan, P.2    Chien, F.Y.3
  • 5
    • 34447135999 scopus 로고    scopus 로고
    • Retinal pigment epithelial tear after intravitreal ranibizumab injections for neovascular age-related macular degeneration
    • Lee G, Lai TY, Chan WM, et al. Retinal pigment epithelial tear after intravitreal ranibizumab injections for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245: 1225-7
    • (2007) Graefes Arch Clin Exp Ophthalmol , vol.245 , pp. 1225-1227
    • Lee, G.1    Lai, T.Y.2    Chan, W.M.3
  • 6
    • 42449095527 scopus 로고    scopus 로고
    • Retinal pigment epithelial tears after injection with intravitreal bevacizumab in exudative age-related macular degeneration
    • Garg S, Brod R, Kim D, et al. Retinal pigment epithelial tears after injection with intravitreal bevacizumab in exudative age-related macular degeneration. Clin Exp Ophthalmol 2008;36:252-6
    • (2008) Clin Exp Ophthalmol , vol.36 , pp. 252-256
    • Garg, S.1    Brod, R.2    Kim, D.3
  • 7
    • 58149240172 scopus 로고    scopus 로고
    • Surveillance for potential adverse effects associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease
    • Wong LJ, Desai RU, Jain A, et al. Surveillance for potential adverse effects associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Retina 2008;28:1151-8
    • (2008) Retina , vol.28 , pp. 1151-1158
    • Wong, L.J.1    Desai, R.U.2    Jain, A.3
  • 8
    • 65349140005 scopus 로고    scopus 로고
    • Can the risk of retinal pigment epithelial tears after bevacizumab treatment be predicted? An optical coherence tomography study
    • Leitritz M, Geliskan F, Inhoffen W, et al. Can the risk of retinal pigment epithelial tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye 2008;22:1504-7
    • (2008) Eye , vol.22 , pp. 1504-1507
    • Leitritz, M.1    Geliskan, F.2    Inhoffen, W.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.